SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible
Securities Fraud Violations by the Board of Directors of Philip Morris International Inc.
Levi & Korsinsky announces it has commenced an investigation of Philip Morris International Inc. (NYSE:PM) concerning
possible violations of federal securities laws and/or breaches of fiduciary duty by the Board of Directors.
A Reuters report published on December 20, 2017 stated that “[f]ormer employees and contractors [of Phillip Morris] have
detailed irregularities in the clinical experiments that underpin Philip Morris International’s application to the FDA for approval
of its iQOS smoking device.” The report went on the state, “Tamara Koval, who worked at the company from 2012 to 2014 and helped
coordinate clinical trials for the device, questioned the quality of some of the researchers and sites contracted to carry out
those experiments,” adding that, “after [Koval] raised concerns about the Polish study with Philip Morris executives in Switzerland
she was excluded from meetings.”
Following this report, shares of Philip Morris fell during intraday trading on December 20, 2017. To obtain additional
information, go to:
http://www.zlkdocs.com/PM-Info-Request-Form-6314
or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut and Washington D.C. The firm’s
attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors
throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar
outcomes.
Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
Tel: 212-363-7500
Toll Free: 877-363-5972
Fax: 212-363-7171
www.zlk.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20171221005932/en/